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Primary renal lymphoma is a rare entity, even more so in children. Children with primary renal lymphoma present with variable
clinical features such as constitutional signs and symptoms, acute kidney injury, palpable abdominal masses, and gross hematuria.
Herein we report a child who presented with seemingly advanced chronic kidney disease and was eventually diagnosed with
primary lymphoma. He responded well to intensive chemotherapy and recovered renal function, although he was left with some
functional limitations as a consequence of his treatment regimen. Our report highlights the importance of keeping neoplastic
conditions under consideration when taking care of children with severe kidney disease of unclear etiology.
1. Introduction
Registry data (https://web.emmes.com/study/ped/annlrept/
annualrept2014.pdf) indicate that as many as 6% of all
children who receive a renal transplant (Tx) present with
end-stage renal disease (ESRD) of unknown etiology. This
has implications both for pre- and post-Tx management,
especially since most such children have an underlying
glomerular disease which can recur after the Tx [1]. Although
children with renal cancers can develop chronic kidney
disease (CKD) at long-term follow-up, presumably as a con-
sequence of the treatment regimen [2], neoplastic conditions
have not been reported, to our knowledge, as a cause of
CKD at the time of initial presentation. We are reporting
a child who presented with what appeared to be advanced
CKD, attributed to an obstructive uropathy and for which
maintenance hemodialysis was initiated. While undergoing
evaluation for a renal Tx, he was diagnosed as having primary
renal lymphoma (PRL) as a cause of his kidney disease
and following initiation of chemotherapy his renal function
dramatically improved such that he was able to come off
dialysis and regain normal renal function. With this report,
we would like to highlight PRL, a rare disease entity, as a
possible cause of severe acute kidney injury and one thatmust
be kept into considerationwhen the clinical picture is unclear.
2. Case Report
A 12-year-old boy was admitted with a 2-month history of
progressively worsening fatigue. He had been noted to be
anemic amonth prior to his hospitalization, with hemoglobin
of 7.9 g/dL and was started on oral iron by his primary care
pediatrician. At his outpatient follow-up visit, because of
persistence of his symptoms, repeat laboratory testing was
performed and showed his hemoglobin had decreased to
7.3 g/dL. His serum potassium was 7mEq/L, serum bicar-
bonate was low at 15mEq/L, and serum creatinine was
elevated at 8.7mg/dL (estimated glomerular filtration rate
[eGFR] 11mL/min/1.73m2). He was admitted to the pediatric
intensive care unit via the emergency roomwhere he received
furosemide and sodium polystyrene. Studies to evaluate his
renal disease included a renal ultrasound which revealed
normal sized kidneys with bilateral grade 2 hydronephrosis
without dilated ureters and with a distended, but thin-walled
bladder; a voiding cystourethrogram showed no reflux and
a normal urethra, but significant after void residual. Other
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studies included serum complements C3 and C4, both of
which were normal, hepatitis B and hepatitis C and HIV
serologies that were all negative, and an antinuclear antibody
thatwas also negative.His urinalysis had a low specific gravity
of 1.006 with no blood or protein. He was urgently started on
hemodialysis because of hyperkalemia and was maintained
on outpatient hemodialysis three times a week at discharge,
with a presumptive diagnosis of advanced CKD likely from
a urologic cause. His past medical history was uneventful
with normal development and growth, and there were no
documented urinary tract infections, unexplained febrile
illnesses, or urinary complaints. For further evaluation of his
renal disease and in preparation for a renal Tx, he underwent
urodynamic studies which showed a normally compliant
low-pressure bladder with complete bladder emptying. Even
though he only hadmoderate hydronephrosis on ultrasound,
due to the severity of his kidney disease, he underwent
bilateral retrograde pyelograms which showed that both
proximal ureters were somewhat medially deviated; the left
proximal ureter had a 1 cm long narrow segment and the
right proximal ureter had a 3 cm long narrowing. Double J
ureteral stents were placed on both sides. Following stenting
his urine output increased, and his renal function improved
but only minimally, to a serum creatinine of 5mg/dl (eGFR
19mL/min/1.73m2). Due to a concern that the narrowingwas
from extrinsic ureteric compression, abdominal and pelvic
CT scans were performed. On these scans, performed about
2 months after his initial renal ultrasound, both kidneys
were noted to be very large and almost entirely replaced
with nonenhancing nodules throughout the parenchyma.
Mild bilateral hydronephrosis was again noted. Also noted
were multiple mixed sclerotic-lytic lesions in the L2 to L5
vertebral bodies; his serum calcium was normal. He was
readmitted to the hospital for further management and
underwent a percutaneous renal biopsywhich established the
diagnosis of diffuse large B-cell lymphoma.The biopsy tissue
showed parenchyma infiltrated by large atypical pleomorphic
lymphoid cells with prominent nucleoli and that stained
positively with CD79A and CD 20. FISH probe for MYC
rearrangement was negative. His bonemarrowwas normal. A
whole body PET scan showed findings consistent with multi-
focal, infiltrative renal lymphoma associated with multifocal
hypermetabolic lymphoma deposits in the axial and appen-
dicular skeleton and retroperitoneal lymph nodes. With a
diagnosis of PRL, he was started on chemotherapy with
vincristine, cyclophosphamide, prednisone, and intrathecal
methotrexate. Following a lack of response to therapy, he
was transitioned to a more aggressive protocol, consisting
of additional doses of vincristine, prednisone, methotrexate,
doxorubicin, etoposide, and intrathecal methotrexate. Over
time, his renal function progressively improved such that
he was able to come off hemodialysis, and at discharge
from the hospital, he had a serum creatinine of 1.7mg/dl
(eGFR 58mL/min/1.73m2). His subsequent clinical course
was complicated by episodes of fever and neutropenia, typhli-
tis, and neurotoxicity from etoposide and vincristine needing
extensive rehabilitation. At his last clinic visit, 5.5 years after
diagnosis and 4 years after completing chemotherapy, his PET
scan showed no hypermetabolic lesions to suggest active dis-
ease, his blood pressure was normal, and his serum creatinine
was stable at 1.2mg/dL (eGFR 94mL/min/1.73m2). On his
most recent ultrasound, he hadmild left hydronephrosis with
a significant reduction in renomegaly; his ureteral stents had
been removed in the interim. He was in school performing
well academically and using a walker for ambulation due to
his residual neurologic injury.
3. Discussion
PRL is a very rare disease entity with a reported incidence
of 0.7% of all extranodal lymphomas, is usually of B-
cell origin, as in our patient, and is typically described
in older adults [3]. The tumor has been hypothesized to
originate from mucosa-associated renal lymphoid tissue
or from lymphatics in the renal capsule [3, 4]. Clinical
presentations include palpable renal masses [3], hematuria,
constitutional symptoms, hypertension [4], and acute kidney
injury [5]. Due to the rarity of this condition, diagnosis is
often delayed and limited therapeutic guidelines are available.
Prognosis is reported to be poor with 25% 1-year survival
[6]. Our patient is unique in that he presented with severe
kidney disease and the consequent anemia, as his initial
presenting manifestation, and was presumed to have CKD.
The etiology of the kidney disease was presumably mainly
from infiltration of the renal parenchyma by the malignant
cells with an added component of extrinsic compression
of the proximal ureters by the intraparenchymal masses.
This is supported by the lack of a significant decline in his
serum creatinine after ureteral stenting and the subsequent
prompt improvement of renal function following start of
chemotherapy.
With this report, we highlight PRL as a possible cause
of acute kidney injury in children and one that should
be thought of when no clear identifiable etiology for the
kidney disease can be established. While rare, the impli-
cations of missing the diagnosis are significant as are the
potential benefits of early diagnosis. In the setting of only
mild hydronephrosis and the absence of atrophic kidneys,
potentially reversible causes of kidney diseasemust be sought
after in children with seemingly advanced CKD.
Conflicts of Interest
The authors declare that there are no conflicts of interest
regarding the publication of this paper.
References
[1] L. Butani, “Children presenting with end-stage renal disease of
unexplained etiology: Implications for disease recurrence after
transplantation,” Pediatric Transplantation, vol. 10, no. 4, pp.
487–490, 2006.
[2] J. Stefanowicz, M. Kosiak, G. Romanowicz, R. Owczuk, E.
Adamkiewicz-Drozyn´ska, and A. Balcerska, “Glomerular filtra-
tion rate and prevalence of chronic kidney disease in Wilms’
tumour survivors,” Pediatric Nephrology, vol. 26, no. 5, pp. 759–
766, 2011.
Case Reports in Medicine 3
[3] S. C. Dash, K. Purohit, S. K. Mohanty, and A. K. Dinda, “An
unusual case of bilateral renal enlargement due to primary renal
lymphoma,” Indian Journal of Nephrology, vol. 21, no. 1, pp. 56–
58, 2011.
[4] A. M. Becker, D. C. Bowers, L. R. Margraf, J. Emmons, and
M. Baum, “Primary renal lymphoma presenting with hyperten-
sion,”Pediatric Blood andCancer, vol. 48, no. 7, pp. 711–713, 2007.
[5] F. Ozaltin, B. Yalc¸in, D. Orhan et al., “An unusual cause of acute
renal failure: Renal lymphoma,”Pediatric Nephrology, vol. 19, no.
8, pp. 912–914, 2004.
[6] L. B. Kandel, D. L.McCullough, L. H. Harrison, R. D.Woodruff,
E. T. Ahl, and H. A. Munitz, “Primary renal lymphoma. Does it
exist?” Cancer, vol. 60, no. 3, pp. 386–391, 1987.
